Cargando…

Antiretroviral (ARV) Therapy in Resource Poor Countries: What do we Need in Real Life?

Significant progresses have been made in the last 5 years towards the ultimate goal to provide universal access to care for all HIV/AIDS patients needing antiretroviral treatment in resource-poor countries. However, many barriers are still to be overcome, including (●) cost of care for the individua...

Descripción completa

Detalles Bibliográficos
Autores principales: Castelli, Francesco, Pietra, Virginio, Diallo, Ismael, Schumacher, Richard F., Simpore, Jacques
Formato: Texto
Lenguaje:English
Publicado: Bentham Open 2010
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2817878/
https://www.ncbi.nlm.nih.gov/pubmed/20148089
http://dx.doi.org/10.2174/1874613601004020028
_version_ 1782177255639744512
author Castelli, Francesco
Pietra, Virginio
Diallo, Ismael
Schumacher, Richard F.
Simpore, Jacques
author_facet Castelli, Francesco
Pietra, Virginio
Diallo, Ismael
Schumacher, Richard F.
Simpore, Jacques
author_sort Castelli, Francesco
collection PubMed
description Significant progresses have been made in the last 5 years towards the ultimate goal to provide universal access to care for all HIV/AIDS patients needing antiretroviral treatment in resource-poor countries. However, many barriers are still to be overcome, including (●) cost of care for the individual, (●) stigma, (●) lack of qualified human resources and infrastructure, especially in the rural setting, (●) rescue drugs for failing patients and (●) pediatric formulations. Priority actions to be promoted if the fight against HIV/AIDS is to be successful include: (i) promoting access to care in the rural areas, (ii) strengthening of basic health infrastructures, (iii) waiving of users’ fee to get ARV, (iv) a larger variety of drugs, with particular regard to fixed dose combination third line drugs and pediatric formulations, (v) local quality training and (vi) high quality basic and translational research. While the universal access to HIV care is crucial in developing countries, a strong emphasis on prevention should be maintained along.
format Text
id pubmed-2817878
institution National Center for Biotechnology Information
language English
publishDate 2010
publisher Bentham Open
record_format MEDLINE/PubMed
spelling pubmed-28178782010-02-10 Antiretroviral (ARV) Therapy in Resource Poor Countries: What do we Need in Real Life? Castelli, Francesco Pietra, Virginio Diallo, Ismael Schumacher, Richard F. Simpore, Jacques Open AIDS J Article Significant progresses have been made in the last 5 years towards the ultimate goal to provide universal access to care for all HIV/AIDS patients needing antiretroviral treatment in resource-poor countries. However, many barriers are still to be overcome, including (●) cost of care for the individual, (●) stigma, (●) lack of qualified human resources and infrastructure, especially in the rural setting, (●) rescue drugs for failing patients and (●) pediatric formulations. Priority actions to be promoted if the fight against HIV/AIDS is to be successful include: (i) promoting access to care in the rural areas, (ii) strengthening of basic health infrastructures, (iii) waiving of users’ fee to get ARV, (iv) a larger variety of drugs, with particular regard to fixed dose combination third line drugs and pediatric formulations, (v) local quality training and (vi) high quality basic and translational research. While the universal access to HIV care is crucial in developing countries, a strong emphasis on prevention should be maintained along. Bentham Open 2010-01-19 /pmc/articles/PMC2817878/ /pubmed/20148089 http://dx.doi.org/10.2174/1874613601004020028 Text en © Castelli et al.; Licensee Bentham Open. http://creativecommons.org/licenses/by-nc/3.0/ This is an open access article licensed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.
spellingShingle Article
Castelli, Francesco
Pietra, Virginio
Diallo, Ismael
Schumacher, Richard F.
Simpore, Jacques
Antiretroviral (ARV) Therapy in Resource Poor Countries: What do we Need in Real Life?
title Antiretroviral (ARV) Therapy in Resource Poor Countries: What do we Need in Real Life?
title_full Antiretroviral (ARV) Therapy in Resource Poor Countries: What do we Need in Real Life?
title_fullStr Antiretroviral (ARV) Therapy in Resource Poor Countries: What do we Need in Real Life?
title_full_unstemmed Antiretroviral (ARV) Therapy in Resource Poor Countries: What do we Need in Real Life?
title_short Antiretroviral (ARV) Therapy in Resource Poor Countries: What do we Need in Real Life?
title_sort antiretroviral (arv) therapy in resource poor countries: what do we need in real life?
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2817878/
https://www.ncbi.nlm.nih.gov/pubmed/20148089
http://dx.doi.org/10.2174/1874613601004020028
work_keys_str_mv AT castellifrancesco antiretroviralarvtherapyinresourcepoorcountrieswhatdoweneedinreallife
AT pietravirginio antiretroviralarvtherapyinresourcepoorcountrieswhatdoweneedinreallife
AT dialloismael antiretroviralarvtherapyinresourcepoorcountrieswhatdoweneedinreallife
AT schumacherrichardf antiretroviralarvtherapyinresourcepoorcountrieswhatdoweneedinreallife
AT simporejacques antiretroviralarvtherapyinresourcepoorcountrieswhatdoweneedinreallife